Home Other Building Blocks 623565-58-2
623565-58-2,MFCD16620641
Catalog No.:AA00EJE9

623565-58-2 | (6,7-Dihydro-4H-pyrazolo[5,1-c][1,4]oxazin-2-yl)methanol

Pack Size
Purity
Availability
Price(USD)
Quantity
  
50mg
95%
3 weeks  
$618.00   $433.00
- +
100mg
95%
3 weeks  
$865.00   $605.00
- +
250mg
95%
3 weeks  
$1,188.00   $832.00
- +
500mg
95%
3 weeks  
$1,806.00   $1,264.00
- +
1g
95%
3 weeks  
$2,283.00   $1,598.00
- +
2.5g
95%
3 weeks  
$4,363.00   $3,054.00
- +
5g
95%
3 weeks  
$6,400.00   $4,480.00
- +
10g
95%
3 weeks  
$9,438.00   $6,607.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00EJE9
Chemical Name:
(6,7-Dihydro-4H-pyrazolo[5,1-c][1,4]oxazin-2-yl)methanol
CAS Number:
623565-58-2
Molecular Formula:
C7H10N2O2
Molecular Weight:
154.1665
MDL Number:
MFCD16620641
SMILES:
OCc1nn2c(c1)COCC2
Properties
Computed Properties
 
Complexity:
142  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
1  
XLogP3:
-1.2  

Downstream Synthesis Route

[1]Venkatesan,AranapakamM.;Agarwal,Atul;Abe,Takao;Ushirogochi,Hideki;Yamamura,Itsuka;Ado,Mihira;Tsuyoshi,Takasaki;DosSantos,Osvaldo;Gu,Yansong;Sum,Fuk-Wah;Li,Zhong;Francisco,Gerry;Lin,Yang-I.;Petersen,PeterJ.;Yang,Youjun;Kumagai,Toshio;Weiss,WilliamJ.;Shlaes,DavidM.;Knox,JamesR.;Mansour,TarekS.[JournalofMedicinalChemistry,2006,vol.49,#15,p.4623-4637]

[2]CurrentPatentAssignee:PFIZERINC-WO2003/93279,2003,A1Locationinpatent:Page/Pagecolumn136

[3]CurrentPatentAssignee:PFIZERINC-US2004/132708,2004,A1

[4]CurrentPatentAssignee:PFIZERINC-US2006/276445,2006,A1Locationinpatent:Page/Pagecolumn41-42

[1]CurrentPatentAssignee:YANGTZERIVERPHARMACEUTICALGROUPCOLTD-CN113429410,2021,ALocationinpatent:Paragraph0318-0319;0323

[2]Venkatesan,AranapakamM.;Agarwal,Atul;Abe,Takao;Ushirogochi,Hideki;Yamamura,Itsuka;Ado,Mihira;Tsuyoshi,Takasaki;DosSantos,Osvaldo;Gu,Yansong;Sum,Fuk-Wah;Li,Zhong;Francisco,Gerry;Lin,Yang-I.;Petersen,PeterJ.;Yang,Youjun;Kumagai,Toshio;Weiss,WilliamJ.;Shlaes,DavidM.;Knox,JamesR.;Mansour,TarekS.[JournalofMedicinalChemistry,2006,vol.49,#15,p.4623-4637]

[3]CurrentPatentAssignee:PFIZERINC-WO2003/93279,2003,A1Locationinpatent:Page/Pagecolumn135-136

[4]CurrentPatentAssignee:PFIZERINC-US2004/132708,2004,A1

[5]CurrentPatentAssignee:PFIZERINC-US2006/276445,2006,A1Locationinpatent:Page/Pagecolumn41

[6]CurrentPatentAssignee:RECURIUMIPHOLDINGSLLC-WO2020/185606,2020,A1Locationinpatent:Paragraph0256

[1]Venkatesan,AranapakamM.;Agarwal,Atul;Abe,Takao;Ushirogochi,Hideki;Yamamura,Itsuka;Ado,Mihira;Tsuyoshi,Takasaki;DosSantos,Osvaldo;Gu,Yansong;Sum,Fuk-Wah;Li,Zhong;Francisco,Gerry;Lin,Yang-I.;Petersen,PeterJ.;Yang,Youjun;Kumagai,Toshio;Weiss,WilliamJ.;Shlaes,DavidM.;Knox,JamesR.;Mansour,TarekS.[JournalofMedicinalChemistry,2006,vol.49,#15,p.4623-4637]

623565-58-2   
Sodium;(R)-6-1-(6,7-dihydro-4H-pyrazolo5,1-c1,4oxazin-2-yl)-meth-(Z)-ylidene-7-oxo-4-thia-1-aza-bicyclo3.2.0hept-2-ene-2-carboxylate 

[1]Venkatesan,AranapakamM.;Agarwal,Atul;Abe,Takao;Ushirogochi,Hideki;Yamamura,Itsuka;Ado,Mihira;Tsuyoshi,Takasaki;DosSantos,Osvaldo;Gu,Yansong;Sum,Fuk-Wah;Li,Zhong;Francisco,Gerry;Lin,Yang-I.;Petersen,PeterJ.;Yang,Youjun;Kumagai,Toshio;Weiss,WilliamJ.;Shlaes,DavidM.;Knox,JamesR.;Mansour,TarekS.[JournalofMedicinalChemistry,2006,vol.49,#15,p.4623-4637]

6,7-dihydro-4H-pyrazolo5,1-c1,4oxazine-2-carboxylicacidmethylester 
  623565-58-2 

[1]CurrentPatentAssignee:ASCENTAGEPHARMASUZHOU;UNIVERSITYOFMICHIGAN;SUZHOUASCENTAGEPHARMACY;ASCENTAGEPHARMAGROUP;ASCENTAGEPHARMACYGROUP-WO2020/103864,2020,A1Locationinpatent:Paragraph1326-1327

[2]CurrentPatentAssignee:SUZHOUYASHENGMEDICINE;ASCENTAGEPHARMAGROUP;MICHIGANSTATEUNIVERSITY;UNIVERSITYOFMICHIGAN;ASCENTAGEPHARMASUZHOU-WO2020/151738,2020,A1Locationinpatent:Paragraph0908

[3]CurrentPatentAssignee:ASCENTAGEPHARMASUZHOU;UNIVERSITYOFMICHIGAN;SUZHOUASCENTAGEPHARMACY;ASCENTAGEPHARMAGROUP;ASCENTAGEPHARMACYGROUP-CN110845520,2020,ALocationinpatent:Paragraph1759;1771-1773

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 623565-58-2
Tags:623565-58-2 Molecular Formula|623565-58-2 MDL|623565-58-2 SMILES|623565-58-2 (6,7-Dihydro-4H-pyrazolo[5,1-c][1,4]oxazin-2-yl)methanol